Showing results (51-60 of 169) with videos related to
Sort By:
Pageof 17
Journal of Psychiatric Research|September 25, 2017
Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomesDouglas L Noordsy, Shirley M Glynn, Catherine A Sugar, et al.Schizophrenia Research|June 27, 2002
Sexual side effects of novel antipsychotic medicationsDonna A Wirshing, Joseph M Pierre, Stephen R Marder, et al.The Journal of Clinical Psychiatry|May 17, 2007
A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophreniaJoseph M Pierre, John H Peloian, Donna A Wirshing, et al.Schizophrenia Bulletin Open|August 15, 2024
Assessment of Negative Symptoms in Clinical Trials of Acute Schizophrenia: Test of a Novel Enrichment StrategySeth C Hopkins, Sasagu Tomioka, Ajay Ogirala, et al.Biological Psychiatry|July 3, 2007
Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled studyStephen R Marder, Michelle Kramer, Lisa Ford, et al.Schizophrenia Bulletin|September 25, 2009
A brief cognitive assessment tool for schizophrenia: construction of a tool for cliniciansIrene M Hurford, Stephen R Marder, Richard S E Keefe, et al.Journal of Substance Use and Addiction Treatment|April 3, 2023
Psychosis among individuals with methamphetamine use disorder is associated with elevated rates of hospitalizations and emergency department visits across an academic health care systemMichael F Zito, Zhe Fei, Yuhui Zhu, et al.Innovations in Clinical Neuroscience|February 8, 2018
Disparity between General Symptom Relief and Remission Criteria in the Positive and Negative Syndrome Scale (PANSS): A Post-treatment Bifactor Item Response Theory ModelAriana E Anderson, Steven P Reise, Stephen R Marder, et al.Biological Psychiatry|January 7, 2003
Prefrontal-posterior parietal networks in schizophrenia: primary dysfunctions and secondary compensationsJavier Quintana, Tiffany Wong, Elena Ortiz-Portillo, et al.Psychiatry Research|May 10, 2014
Reliability, validity and ability to detect change of the PANSS negative symptom factor score in outpatients with schizophrenia on select antipsychotics and with prominent negative or disorganized thought symptomsChris J Edgar, Thomas Blaettler, Dragana Bugarski-Kirola, et al.Pageof 17